Both in Pharmaceuticals
Verrica Pharmaceuticals vs Citius Oncology
Over the past year VRCA returned −7.6% and CTOR returned −67.1%; their daily moves had a correlation of 0.13.
VRCA −7.6% CTOR −67.1%Growth of $1, one year, split-adjusted
| Metric | VRCA | CTOR |
|---|---|---|
| Price | $3.29 | $0.5500 |
| Market cap | $56.5M | $58.2M |
| Today | +2.49% | −7.42% |
| 1 month | −23.7% | −37.0% |
| 6 months | −54.1% | −42.5% |
| Year to date | −60.4% | −45.0% |
| 1 year | −8.9% | −68.6% |
| Revenue growth (YoY) | −53.8% | — |
| Gross margin | 85.0% | 67.1% |
| Net margin | −224.4% | −597.4% |
| P/E (TTM) | — | — |
| Price / sales | 1.9× | 8.2× |
| Net cash | $9.8M | $10.2M |
| Dividend yield | — | — |
| Volatility (60d) | 62.8% | 98.9% |
| Short % of float | 2.5% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).